Related Experiment Video

Updated: Oct 3, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Preventive and therapeutic strategies for respiratory syncytial virus infection

O Vujovic1, J Mills

  • 1Macfarlane Burnet Centre for Medical Research, Fairfield, Victoria, Australia.

Current Opinion in Pharmacology
|January 5, 2002
PubMed

Insights

Respiratory syncytial virus (RSV) causes severe pneumonia in infants and the elderly. While palivizumab offers some protection, new vaccines and treatments are urgently needed for this common respiratory infection.

Area of Science:

  • Virology
  • Immunology
  • Pediatrics

Background:

  • Respiratory syncytial virus (RSV) is a major cause of infant pneumonitis.
  • High-risk infants and the elderly are particularly vulnerable to severe RSV infection.
  • Current interventions like palivizumab have limitations in optimal and cost-effective use.

Purpose of the Study:

  • To review the current landscape of respiratory syncytial virus (RSV) prevention and treatment.
  • To highlight recent advances in vaccine development and antiviral therapies for RSV.
  • To discuss the challenges and future directions in managing RSV infections.

Main Methods:

  • Literature review of recent research on RSV.
  • Analysis of clinical trial data for vaccines and therapeutics.
  • Evaluation of the efficacy and limitations of existing interventions.

Main Results:

  • Passive immunoprophylaxis with palivizumab reduces RSV hospitalizations by approximately 50% in high-risk infants.
  • Live attenuated RSV vaccines show promise and are in clinical trials.
  • The efficacy of ribavirin for treating established RSV infection is questionable, and new chemotherapeutics are emerging.

Conclusions:

  • RSV prevention and treatment strategies are evolving.
  • Development of effective RSV vaccines is a key research focus.
  • New therapeutic agents are needed to combat RSV infections effectively.

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...